Terms of Service

Critical — Read Carefully

• Content Accuracy: Companies are solely responsible for the accuracy, completeness, legality, and regulatory compliance of all content they upload to Dalil, including scientific documents, prescribing information, publications, compliance materials, and guardrail configurations. Dalil processes and retrieves this content as-is.
• Regulatory Compliance: Companies are solely responsible for ensuring that their use of Dalil complies with all applicable laws, regulations, and industry guidelines, including but not limited to FDA regulations, OIG guidelines, PhRMA Code, EFPIA Code, and any applicable promotional and medical affairs regulations in their operating jurisdictions.
• Guardrail Configuration: Companies are solely responsible for configuring appropriate guardrails, prohibited topics, required disclaimers, escalation triggers, and response boundaries. Dalil provides the tools to define and enforce guardrails but does not determine what the guardrails should be. Inadequate guardrail configuration is the company's responsibility.
• HCP Engagement: Companies are solely responsible for determining which HCPs to invite to Virtual MSL Visits, for what purpose, and with what frequency. Dalil facilitates the engagement but does not direct or control it.
• Adverse Event Reporting: Companies are solely responsible for their adverse event (AE) reporting obligations. While Dalil includes AE awareness features (prompts in the AI system, escalation triggers), the platform does not replace a company's pharmacovigilance obligations. Companies must maintain their own AE reporting systems and processes independent of Dalil.
• Content Review: Companies are responsible for reviewing and validating AI-generated responses, transcripts, and intelligence outputs. AI-generated content should not be treated as a substitute for human medical, legal, or regulatory review.
• Off-Label Use: Companies are responsible for ensuring that the content uploaded to Dalil does not promote off-label use of their products unless permitted by applicable regulations.

Critical — Read Carefully

Dalil uses artificial intelligence, including large language models provided by third parties, to generate responses during Virtual MSL Visits, create conversation transcripts, extract intelligence insights, and generate reports.

• AI-generated content may be inaccurate, incomplete, outdated, or misleading. While Dalil is designed to respond only from uploaded approved content using a closed-loop retrieval-augmented generation (RAG) architecture, no AI system is perfect. Responses may contain errors, omissions, or misinterpretations of source material.
• Dalil does not provide medical advice. The platform is a scientific information resource, not a healthcare provider. AI-generated responses are not a substitute for professional medical judgment, clinical decision-making, or patient care.
• Dalil does not guarantee regulatory compliance of AI-generated responses. Companies are responsible for reviewing AI outputs for compliance with their specific regulatory requirements and internal policies.
• Dalil does not guarantee the completeness or accuracy of citation references. While the platform is designed to cite source documents for every factual claim, citations may occasionally be incomplete, incorrectly attributed, or reference the wrong page or section.
• Users should not rely solely on Dalil's AI outputs for clinical, regulatory, legal, or business decisions. All AI-generated content should be reviewed by qualified professionals.

Critical — Read Carefully

Dalil is currently in an early access / beta phase. The platform is under active development and may contain bugs, errors, or incomplete features.

By using Dalil during the early access period, you acknowledge and accept that:

• The platform may not function as expected at all times
• Features may be added, changed, or removed without advance notice
• Data processing and AI outputs may have higher error rates than a mature, generally available product
• Service interruptions may occur for maintenance, updates, or unforeseen issues
• We are actively iterating on the platform based on user feedback and our own development roadmap

Early access users are encouraged to report issues, bugs, and feedback to ahmad@dalil.bio.

This early access acknowledgment does not limit any other disclaimers or limitations of liability in these Terms.

Critical — Read Carefully

TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, DALIL AND ITS OPERATORS, EMPLOYEES, CONTRACTORS, AND AFFILIATES SHALL NOT BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED TO:

• Loss of profits, revenue, data, or business opportunities
• Regulatory penalties or fines arising from use of the platform
• Damages arising from AI-generated content, including inaccurate responses, incorrect citations, or missed adverse event signals
• Damages arising from unauthorized access to data, despite our security measures
• Damages arising from service interruptions, bugs, or errors
• Damages arising from third-party service failures (AI model providers, hosting providers, email delivery services)

DALIL'S TOTAL AGGREGATE LIABILITY FOR ALL CLAIMS SHALL NOT EXCEED THE AMOUNT PAID BY THE COMPANY TO DALIL IN THE TWELVE (12) MONTHS PRECEDING THE EVENT GIVING RISE TO THE CLAIM.

THE PLATFORM IS PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, AND NON-INFRINGEMENT. DALIL DOES NOT WARRANT THAT AI-GENERATED CONTENT WILL BE ACCURATE, COMPLETE, UP-TO-DATE, OR COMPLIANT WITH ANY REGULATORY REQUIREMENTS.

Critical — Read Carefully

Companies agree to indemnify, defend, and hold harmless Dalil and its operators, employees, contractors, and affiliates from and against any and all claims, damages, losses, liabilities, costs, and expenses (including reasonable legal fees) arising from or related to:

• The company's use of the platform
• Content uploaded by the company, including its accuracy, legality, and regulatory compliance
• The company's violation of these Terms
• The company's violation of applicable laws, regulations, or industry codes
• Claims by HCPs, patients, or third parties related to the company's use of Dalil
• Regulatory actions, investigations, or penalties related to the company's use of AI-generated content in medical affairs
• Failure to maintain adequate adverse event reporting processes